The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Spangler Jonathan since 2005.
The trader's CIK number is 1312160.
At the time of the last reporting, Spangler Jonathan was the Chief Patent Counsel of Nuvasive Inc. (stock ticker symbol NUVA).
Also see all insider trading activities at Nuvasive Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2006 | NUVA | 0 | $0 | 36,500 | $706,226 | 33,500 | $21,105 |
2005 | NUVA | 0 | $0 | 21,000 | $328,053 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2006-12-28 | NUVA | Option Ex | 8,500 | .63 | 5,355 |
2006-12-28 | NUVA | Sale | 8,500 | 23.65 | 201,059 |
2006-11-28 | NUVA | Sale | 1,000 | 21.84 | 21,837 |
2006-11-28 | NUVA | Option Ex | 1,000 | .63 | 630 |
2006-10-26 | NUVA | Option Ex | 1,000 | .63 | 630 |
2006-10-26 | NUVA | Sale | 1,000 | 24.07 | 24,074 |
2006-09-28 | NUVA | Sale | 1,000 | 20.67 | 20,670 |
2006-09-28 | NUVA | Option Ex | 1,000 | .63 | 630 |
2006-08-25 | NUVA | Option Ex | 1,000 | .63 | 630 |
2006-08-25 | NUVA | Sale | 1,000 | 18.73 | 18,735 |
2006-07-28 | NUVA | Option Ex | 6,000 | .63 | 3,780 |
2006-07-28 | NUVA | Sale | 6,000 | 17.20 | 103,212 |
2006-06-27 | NUVA | Option Ex | 15,000 | .63 | 9,450 |
2006-06-27 | NUVA | Sale | 15,000 | 17.46 | 261,840 |
2006-02-28 | NUVA | Sale | 1,500 | 18.58 | 27,867 |
2006-01-30 | NUVA | Sale | 1,500 | 17.95 | 26,932 |
2005-12-28 | NUVA | Sale | 1,500 | 18.14 | 27,214 |
2005-11-28 | NUVA | Sale | 1,500 | 17.11 | 25,672 |
2005-10-27 | NUVA | Sale | 1,500 | 18.67 | 28,006 |
2005-09-28 | NUVA | Sale | 1,500 | 18.03 | 27,045 |
2005-08-25 | NUVA | Sale | 1,500 | 19.22 | 28,830 |
2005-07-28 | NUVA | Sale | 1,500 | 19.26 | 28,890 |
2005-06-27 | NUVA | Sale | 1,500 | 17.06 | 25,589 |
2005-05-26 | NUVA | Sale | 1,500 | 15.05 | 22,575 |
2005-04-27 | NUVA | Sale | 1,500 | 13.90 | 20,850 |
2005-03-28 | NUVA | Sale | 7,500 | 12.45 | 93,382 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Spangler Jonathan (Chief Patent Counsel of Nuvasive Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.